Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares OutstandingShares Outstanding
Ratios

Iradimed (IRMD) Other Gross PP&E Adjustments (2016 - 2026)

Iradimed has reported Other Gross PP&E Adjustments over the past 14 years, most recently at $29.3 million for Q1 2026.

  • Quarterly Other Gross PP&E Adjustments rose 17.85% to $29.3 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $29.3 million through Mar 2026, up 17.85% year-over-year, with the annual reading at $28.9 million for FY2025, 36.12% up from the prior year.
  • Other Gross PP&E Adjustments was $29.3 million for Q1 2026 at Iradimed, up from $28.9 million in the prior quarter.
  • Over five years, Other Gross PP&E Adjustments peaked at $29.3 million in Q1 2026 and troughed at $2.7 million in Q1 2022.
  • The 5-year median for Other Gross PP&E Adjustments is $11.5 million (2024), against an average of $15.2 million.
  • Year-over-year, Other Gross PP&E Adjustments surged 269.25% in 2023 and then increased 17.69% in 2024.
  • A 5-year view of Other Gross PP&E Adjustments shows it stood at $3.6 million in 2022, then skyrocketed by 212.16% to $11.3 million in 2023, then surged by 87.81% to $21.3 million in 2024, then surged by 36.12% to $28.9 million in 2025, then rose by 1.32% to $29.3 million in 2026.
  • Per Business Quant, the three most recent readings for IRMD's Other Gross PP&E Adjustments are $29.3 million (Q1 2026), $28.9 million (Q4 2025), and $28.5 million (Q3 2025).